Olympus Launches Line of Airway Mobilescopes
All-in-one Design Allows Use by Anesthesiologists, Pulmonologists, and ICU Caregivers for a Range of Recordable, Sharable Airway Management Procedures
News provided by
Share this article
Share this article
CENTER VALLEY, Pa., May 10, 2021 /PRNewswire/ Olympus announced today the FDA 510(k) clearance of its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures. Anesthesiologists, pulmonologists and providers of critical care and intensive care will appreciate the anytime/anywhere benefits, the digital capture capability, and small footprint of the MAF models all-in-one design.
The new Olympus Airway Mobilescopes enable flexible and portable airway management for anesthesiologists, pulmonologists and providers of critical care and intensive care, who will appreciate the anytime/anywhere benefits, the digital capture capability, and small footp